Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence and analysis of microbiological factors associated with phenotypic heterogeneous resistance to carbapenems in Acinetobacter baumannii.

International journal of antimicrobial agents - 1 Jun 2012

Fernández Cuenca Felipe, Sánchez M del Carmen Gómez, Caballero-Moyano Francisco Javier, Vila Jordi, Martínez-Martínez Luis, Bou Germán, Baño Jesús Rodríguez, Pascual Alvaro

Abstract excerpt

The objectives of this study were to determine the prevalence of Acinetobacter baumannii with phenotypic heterogeneous resistance (PHR) to carbapenems (colonies inside the halo of inhibition) and to analyse its association with several microbiological variables. Acinetobacter baumannii isolates collected in Spain were used to analyse: (i) minimum inhibitory concentrations (MICs) of carbapenems; (ii)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acinetobacter baumannii
Share to Acinetobacter Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Anti-Bacterial Agents

Share to beta-Lactamases

Share to Carbapenems

Share to Drug Resistance, Bacterial

Share to Microbial Sensitivity Tests

Source

Identifiers

PMID: 22445494
DOI: 10.1016/j.ijantimicag.2012.01.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence and analysis of microbiological factors associated with phenotypic heterogeneous resistance to carbapenems in Acinetobacter baumannii.PMID 22445494Read ↗

Clonality, virulence determinants, and profiles of resistance of clinical Acinetobacter baumannii isolates obtained from a Spanish hospitalSemantic proximity Read ↗

Epidemiological and clinical features associated with colonisation/infection by Acinetobacter baumannii with phenotypic heterogeneous resistance to carbapenemsSemantic proximity Read ↗

Genotypic diversity of imipenem resistant isolates of Acinetobacter baumannii in Spain.Semantic proximity Read ↗

Phenotypic and genotypic characterization of carbapenem-resistant Acinetobacter baumannii isolates from Egypt.Semantic proximity Read ↗

Understanding the Molecular Pathways of Colistin Heteroresistance in Multidrug-Resistant Acinetobacter baumanniiSemantic proximity Read ↗

Indications of carbapenem resistance evolution through heteroresistance as an intermediate stage in Acinetobacter baumannii after carbapenem administration.Semantic proximity Read ↗

Expression of Efflux Pumps, Porins and Genotypic Insight Into the Carbapenem Resistance in Acinetobacter BaumanniiSemantic proximity Read ↗

Epidemiology of the Acinetobacter-derived cephalosporinase, carbapenem-hydrolysing oxacillinase and metallo-β-lactamase genes, and of common insertion sequences, in epidemic clones of Acinetobacter baumannii from Spain.Semantic proximity Read ↗

Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic optionsSemantic proximity Read ↗

Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii.Semantic proximity Read ↗

High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia.Semantic proximity Read ↗

Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.